⚑Today
✨Today's leadDoctors Complete First Bone Marrow Transplant From Deceased Donor for Non-Malignant Disease🎈For kidsSouth Carolina tract beside wildlife refuge to be permanently conserved🌿NatureFormer ocean liner S.S. United States becomes the world's largest artificial reef⚽SportsLindy Duncan wins her first LPGA title on attempt 222🎨Culture & ideasA Lost Altdorfer Landscape Surfaces After 70 Years Privately HeldπŸ”¬Science & healthPeople who control HIV without treatment may help find a cureπŸ’›KindnessA laid-off man began mowing lawns for free and 2,100 volunteers joinedπŸ›οΈPoliticsLos Angeles bans oil drilling after a decade of neighborhood pressureπŸš€ProgressPhiladelphia repaired a collapsed interstate in 12 days

Single-cell study finds shared epigenetic signature in breast tumours

Nature 11 November 2026 2 min read

In short

  • Single-cell epigenetic analyses found a signature shared across patients.
  • The signature may help identify patients at increased risk of relapse.
  • The paper says it may help; it does not describe a tool already in clinical use.

Why it's good news

Relapse risk shapes how aggressively breast cancer is treated after surgery. A signature shared across patients could help match care to those most at risk, if it holds up. This is research so far, and any clinical use would need further testing.

Advertisement

From Nature

Nature, Published online: 11 November 2026; doi:10.1038/s41586-026-11230-y Single-cell epigenetic analyses reveal a conserved epigenetic signature across patients that may help identify those at increased risk for disease relapse in breast cancer.

Read the full story at Nature Opens the publisher's site in a new tab.

Ask this story

An AI model answers from the material behind this story only, with a link to the source. Your question is sent to our AI provider and isn't stored. See Privacy.

More like this

Advertisement
AdMobile anchor